Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.

Edward A Pankey, Matthew Epps, Bobby D Nossaman, Albert L Hyman, Philip J Kadowitz
{"title":"Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.","authors":"Edward A Pankey,&nbsp;Matthew Epps,&nbsp;Bobby D Nossaman,&nbsp;Albert L Hyman,&nbsp;Philip J Kadowitz","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Pulmonary arterial hypertension (PAH) is a devastating disease with limited therapeutic options. Moreover, when PAH occurs in patients diagnosed with systemic sclerosis, worse outcomes are observed. The purpose of this review is to discuss the etiologies of PAH found in the systemic sclerosis patient, limitations of current medical therapies, and, finally, potential therapies for patients with this combination.</p>","PeriodicalId":89802,"journal":{"name":"Journal of clinical rheumatology & musculoskeletal medicine","volume":"1 2","pages":"11-20"},"PeriodicalIF":0.0000,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636503/pdf/nihms302667.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical rheumatology & musculoskeletal medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pulmonary arterial hypertension (PAH) is a devastating disease with limited therapeutic options. Moreover, when PAH occurs in patients diagnosed with systemic sclerosis, worse outcomes are observed. The purpose of this review is to discuss the etiologies of PAH found in the systemic sclerosis patient, limitations of current medical therapies, and, finally, potential therapies for patients with this combination.

肺动脉高压——系统性硬化症的致命并发症。
肺动脉高压(PAH)是一种破坏性疾病,治疗选择有限。此外,当PAH发生在诊断为系统性硬化症的患者时,观察到的结果更差。本综述的目的是讨论在系统性硬化症患者中发现的多环芳烃的病因,当前药物治疗的局限性,最后,对这种联合治疗的患者的潜在治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信